New specific long-acting somatostatin analogues in the treatment of pancreatic endocrine tumours
S.R. Bloom+7 more
openalex +1 more source
The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat [PDF]
Hideo Sakurai+2 more
openalex +1 more source
Inhibition by somatostatin of insulin release from isolated pancreatic islets [PDF]
Hiroshi Okamoto+4 more
openalex +1 more source
Effect of somatostatin on glucose-induced 45Ca uptake in the pancreatic islets.
Fukashi Ishibashi+3 more
openalex +2 more sources
Vasoactive intestinal peptide stimulates pancreatic somatostatin release [PDF]
Eli Ipp, Richard Dobbs, Roger H. Unger
openalex +1 more source
Studies on the Measurements of Somatostatin by Radioimmunoassay
Mitsuyasu Itoh+2 more
openalex +2 more sources
Effects of Somatostatin (SRIF) Infusion on Glucose Homeostasis in Newborn Lambs: Evidence for a Significant Role of Glucagon [PDF]
Mark A. Sperling+3 more
openalex +1 more source
Abstract figure legend Somatostatin binds to a G‐protein‐coupled receptor to inhibit the release of catecholamine from chromaffin cells. This action has no impact on Ca2+ levels and is similar for Ca2+ entry through voltage‐gated Ca2 channels and for Ca2+ mobilization from the endoplasmic reticulum.
Jinbo Cheng, Meyer B. Jackson
wiley +1 more source
Somatostatin Release from Isolated Perfused Rat Pancreas: Possible Role of Endogenous Somatostatin on Insulin Release [PDF]
Seizo Kadowaki+9 more
openalex +1 more source
Abstract figure legend The incretin system in obesity. The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) (yellow) and glucagon‐like peptide‐1 (GLP‐1) (blue) are produced by the proximal and distal small intestinal epithelium, where they are released postprandially into the bloodstream to modulate a myriad of physiological and ...
Constanza Alcaino+2 more
wiley +1 more source